Supplement
Ocoxin clinical trials
Keep track of what changes. Save the Ocoxin studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Name
Combined with it in one product
Studies by the year they started
7 studies that test it; most in 2018 (4)
| Year | Studies |
|---|---|
| 2018 | 4 |
| 2019 | 1 |
| 2024 | 1 |
| 2025 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 6 · Other 1
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses Ocoxin is read from its arms, and is right about nine times in ten.
Testing it · 7
- Pre-habilitation Within ERAS Protocol for Gynecologic Oncology Surgery: The Pre_ERAS StudyRecruitingNot applicableAristotle University Of ThessalonikiNCT07210164Written as Ocoxin
- Effect and Safety of Ocoxin Oral Solution on the Quality of Life of Paediatric Patients With Advanced Stage Solid TumoursNot yet recruitingNot applicableCatalysis SLNCT06363201Written as Ocoxin Oral solution
- Evaluation Glizigen® and Ocoxin®-Viusid® in High-grade Cervical Intraepithelial LesionsRecruitingPhase 2Catalysis SLNCT03549273Written as Glizigen® + Ocoxin-Viusid®
- Evaluation of Ocoxin®-Viusid® in Advanced Stomach Cancer and Gastric Esophagogastric JunctionCompletedPhase 2Catalysis SLNCT03549494Written as Ocoxin-Viusid®
- Evaluation of Ocoxin®-Viusid® in Metastatic Colorectal AdenocarcinomaCompletedPhase 2Catalysis SLNCT03559543Written as Ocoxin-Viusid
- Evaluation of Ocoxin-Viusid® in Advanced Pancreatic AdenocarcinomaCompletedPhase 2Catalysis SLNCT03717298Written as Ocoxin-Viusid®
- Evaluation of Ocoxin-Viusid® in Advanced or Metastatic Ovarian Epithelial CancerCompletedPhase 2Catalysis SLNCT03562897Written as Ocoxin-Viusid